Literature DB >> 27797882

Visual disturbance with systemic symptoms: old lessons revisited.

Megan E Hume1, Peter M Fernandes2,3, Kirsty MacLean4, Euan McRorie5, Richard Davenport5.   

Abstract

We describe a retired physician who presented with visual disturbance and systemic symptoms. The presence of general malaise, headache and scalp tenderness, with raised inflammatory markers, suggested that giant cell arteritis (GCA) was the likely diagnosis. Rapid response to initial steroid therapy and histological evidence of inflammation in the temporal artery supported this diagnosis. The character of these visual symptoms was, however, atypical for GCA. The patient, who had heart valve disease, subsequently deteriorated and developed further symptoms warranting investigation of bacterial endocarditis. Retinal emboli are a recognised complication of endocarditis, which could account for these visual symptoms. Moreover, interpretation of the temporal artery biopsy is limited in the context of existing steroid therapy. Our patient was consequently diagnosed with bacterial endocarditis. This case reminds us to consider the wider differential diagnoses for headache, visual disturbance and systemic symptoms, where echocardiogram and blood cultures may be crucial to reach the diagnosis. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27797882      PMCID: PMC5093805          DOI: 10.1136/bcr-2016-217010

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  Recent advances in diagnostic strategies for giant cell arteritis.

Authors:  Tanaz A Kermani; Kenneth J Warrington
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

2.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.

Authors:  G G Hunder; D A Bloch; B A Michel; M B Stevens; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

3.  BSR and BHPR guidelines for the management of giant cell arteritis.

Authors:  Bhaskar Dasgupta; Frances A Borg; Nada Hassan; Leslie Alexander; Kevin Barraclough; Brian Bourke; Joan Fulcher; Jane Hollywood; Andrew Hutchings; Pat James; Valerie Kyle; Jennifer Nott; Michael Power; Ash Samanta
Journal:  Rheumatology (Oxford)       Date:  2010-04-05       Impact factor: 7.580

4.  Neurological complication of infective endocarditis mimicking temporal arteritis.

Authors:  Valeria Terruso; Ivan Bonanni; Lavinia Dinia; Cinzia Canepa; Carlo Gandolfo; Massimo Del Sette
Journal:  Eur Neurol       Date:  2008-01-29       Impact factor: 1.710

Review 5.  Surgery for infective endocarditis: who and when?

Authors:  Bernard D Prendergast; Pilar Tornos
Journal:  Circulation       Date:  2010-03-09       Impact factor: 29.690

6.  Our approach to the diagnosis and treatment of polymyalgia rheumatica and giant cell (temporal) arteritis.

Authors:  V Quick; J R Kirwan
Journal:  J R Coll Physicians Edinb       Date:  2012

7.  Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.

Authors:  Mona Parikh; Neil R Miller; Andrew G Lee; Peter J Savino; M Noel Vacarezza; Wayne Cornblath; Eric Eggenberger; Aileen Antonio-Santos; Karl Golnik; Randy Kardon; Michael Wall
Journal:  Ophthalmology       Date:  2006-08-01       Impact factor: 12.079

8.  How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis?

Authors:  A A Achkar; J T Lie; G G Hunder; W M O'Fallon; S E Gabriel
Journal:  Ann Intern Med       Date:  1994-06-15       Impact factor: 25.391

Review 9.  Polymyalgia rheumatica and giant-cell arteritis.

Authors:  Carlo Salvarani; Fabrizio Cantini; Gene G Hunder
Journal:  Lancet       Date:  2008-07-19       Impact factor: 79.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.